Concepedia

Author

Christian Teschendorf

Ruhr University Bochum

Also Known As

C Teschendorf, C. Teschendorf, Christian Teschendorf, Teschendorf, Christian

62

Publications

4K

Citations

17

H-Index

46

Concepts

All Affiliations

Ruhr University BochumHeidelberg UniversitySt. Josefs HospitalUniversitätsklinikum Knappschaftskrankenhaus BochumNational Center for Tumor Diseases
CT

About

Christian Teschendorf is an author at Ruhr University Bochum specializing in medicine, radiation oncology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

11

2.9K

2

Cell Biology

3

3

121

3

Health Sciences

2

2

96

4

Allergy

2

2

40

5

Gastroenterology

1

1

2.4K

Christian Teschendorf

×

23

Publications

3.9K

Citations

15

H-Index

YearCitations

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

Salah‐Eddin Al‐Batran, Nils Homann, Claudia Pauligk,

The Lancet

2019

2.4K

Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p

Kai Neben, Henk M. Lokhorst, Anna Jauch,

Blood

2011

353

5-Fluorouracil induces arterial vasocontractions

T Südhoff, M. Enderle, Michaela Pahlke,

Annals of Oncology

2004

165

Blood‐based detection of <i><scp>RAS</scp></i> mutations to guide anti‐<scp>EGFR</scp> therapy in colorectal cancer patients: concordance of results from circulating tumor <scp>DNA</scp> and tissue‐based <i><scp>RAS</scp></i> testing

Wolff Schmiegel, Rodney J. Scott, S Dooley,

Molecular Oncology

2017

159

Comparison of the EF-1 alpha and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus.

Christian Teschendorf, Kenneth H. Warrington, Dietmar W. Siemann,

PubMed

2003

107

Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in <i>KRAS</i>-Mutant Pancreatic and Colorectal Cancer

Jörn Weisner, Ina Landel, Christoph Reintjes,

Cancer Research

2019

88

FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2–Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group

Ralf‐Dieter Hofheinz, Kirsten Merx, Georg Martin Haag,

Journal of Clinical Oncology

2022

86

Induction of Interleukin-6 by Hepatitis C Virus Core Protein in Hepatitis C–Associated Mixed Cryoglobulinemia and B-Cell Non–Hodgkin's Lymphoma

Georg Feldmann, Hans Dieter Nischalke, Jacob Nattermann,

Clinical Cancer Research

2006

83

Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2-positive resectable esophagogastric adenocarcinoma: Final results of the PETRARCA multicenter randomized phase II trial of the AIO.

Ralf‐Dieter Hofheinz, Georg Martin Haag, Thomas J. Ettrich,

Journal of Clinical Oncology

2020

83

Gene therapy delivery of endostatin enhances the treatment efficacy of radiation

Wenyin Shi, Christian Teschendorf, Nicholas Muzyczka,

Radiotherapy and Oncology

2003

57

Page 1